MTHFR and TYMS genotypes influence TPMT activity and its differential modulation in males and females

Clinical Biochemistry

Volumn 43, Issue 1-2, 2010, Pages 37-42

  Karas Kuzelicki, Natasa ^a   Milek, Miha ^a   Mlinaric Rascan, Irena ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

6 mercaptopurine; MTHFR; Pharmacogenetics; TPMT; TYMS

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); MERCAPTOPURINE; THIOPURINE METHYLTRANSFERASE; THYMIDYLATE SYNTHASE;

ADULT; ARTICLE; ENZYME ACTIVITY; ERYTHROCYTE; FEMALE; GENOTYPE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; MODULATION; NORMAL HUMAN; PHARMACOGENETICS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN INTERACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEX DIFFERENCE; WILD TYPE;

6-MERCAPTOPURINE; ADOLESCENT; ADULT; ANTIMETABOLITES, ANTINEOPLASTIC; FEMALE; FOLIC ACID; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); METHYLTRANSFERASES; SEX FACTORS; THYMIDYLATE SYNTHASE; YOUNG ADULT;

EID: 72649094180     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2009.09.003     Document Type: Article

References (28)

1. Otterness D., Szumlanski C., Lennard L., Klemetsdal B., Aarbakke J., Park-Hah J.O., et al. Human thiopurine methyltransferase pharmacogenetics: gene sequence polymorphisms. Clin. Pharmacol. Ther. 62 (1997) 60-73
2. Wang L., Nguyen T.V., McLaughlin R.W., Sikkink L.A., Ramirez-Alvarado M., and Weinshilboum R.M. Human thiopurine S-methyltransferase pharmacogenetics: variant allozyme misfolding and aggresome formation. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 9394-9399
3. Coulthard S.A., Howell C., Robson J., and Hall A.G. The relationship between thiopurine methyltransferase activity and genotype in blasts from patients with acute leukemia. Blood 92 (1998) 2856-2862
4. Evans W.E., Hon Y.Y., Bomgaars L., Coutre S., Holdsworth M., Janco R., et al. Preponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine or azathioprine. J. Clin. Oncol. 19 (2001) 2293-2301
5. McLeod H.L., Coulthard S., Thomas A.E., Pritchard S.C., King D.J., Richards S.M., et al. Analysis of thiopurine methyltransferase variant alleles in childhood acute lymphoblastic leukaemia. Br. J. Haematol. 105 (1999) 696-700
6. Milek M., Murn J., Jaksic Z., Lukac Bajalo J., Jazbec J., and Mlinaric Rascan I. Thiopurine S-methyltransferase pharmacogenetics: genotype to phenotype correlation in the Slovenian population. Pharmacology 77 (2006) 105-114
7. Scheuermann T.H., Keeler C., and Hodsdon M.E. Consequences of binding an S-adenosylmethionine analogue on the structure and dynamics of the thiopurine methyltransferase protein backbone. Biochemistry 43 (2004) 12198-12209
8. Tai H.L., Krynetski E.Y., Schuetz E.G., Yanishevski Y., and Evans W.E. Enhanced proteolysis of thiopurine S-methyltransferase (TPMT) encoded by mutant alleles in humans (TPMT*3A, TPMT*2): mechanisms for the genetic polymorphism of TPMT activity. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 6444-6449
9. Ogino S., and Wilson R.B. Genotype and haplotype distributions of MTHFR677C>T and 1298A>C single nucleotide polymorphisms: a meta-analysis. J. Hum. Genet. 48 (2003) 1-7
10. Chiang E.P., Wang Y.C., and Tang F.Y. Folate restriction and methylenetetrahydrofolate reductase 677T polymorphism decreases adoMet synthesis via folate-dependent remethylation in human-transformed lymphoblasts. Leukemia 21 (2007) 651-658
11. Horie N., Aiba H., Oguro K., Hojo H., and Takeishi K. Functional analysis and DNA polymorphism of the tandemly repeated sequences in the 5′-terminal regulatory region of the human gene for thymidylate synthase. Cell Struct. Funct. 20 (1995) 191-197
12. Gellekink H., Blom H.J., and den Heijer M. Associations of common polymorphisms in the thymidylate synthase, reduced folate carrier and 5-aminoimidazole-4-carboxamide ribonucleotide transformylase/inosine monophosphate cyclohydrolase genes with folate and homocysteine levels and venous thrombosis risk. Clin. Chem. Lab. Med. 45 (2007) 471-476
13. Trinh B.N., Ong C.N., Coetzee G.A., Yu M.C., and Laird P.W. Thymidylate synthase: a novel genetic determinant of plasma homocysteine and folate levels. Hum. Genet. 111 (2002) 299-302
14. Ameyaw M.M., Collie-Duguid E.S., Powrie R.H., Ofori-Adjei D., and McLeod H.L. Thiopurine methyltransferase alleles in British and Ghanaian populations. Hum. Mol. Genet. 8 (1999) 367-370
15. Marsh S., Collie-Duguid E.S., Li T., Liu X., and McLeod H.L. Ethnic variation in the thymidylate synthase enhancer region polymorphism among Caucasian and Asian populations. Genomics 58 (1999) 310-312
16. Gisbert J.P., Gomollon F., Cara C., Luna M., Gonzalez-Lama Y., Pajares J.M., et al. Thiopurine methyltransferase activity in Spain: a study of 14,545 patients. Dig. Dis. Sci. 52 (2007) 1262-1269
17. Klemetsdal B., Straume B., Wist E., and Aarbakke J. Identification of factors regulating thiopurine methyltransferase activity in a Norwegian population. Eur. J. Clin. Pharmacol. 44 (1993) 147-152
18. Tamm R., Oselin K., Kallassalu K., Magi R., Anier K., Remm M., et al. Thiopurine S-methyltransferase (TPMT) pharmacogenetics: three new mutations and haplotype analysis in the Estonian population. Clin. Chem. Lab. Med. 46 (2008) 974-979
19. Ganiere-Monteil C., Medard Y., Lejus C., Bruneau B., Pineau A., Fenneteau O., et al. Phenotype and genotype for thiopurine methyltransferase activity in the French Caucasian population: impact of age. Eur. J. Clin. Pharmacol. 60 (2004) 89-96
20. Oselin K., Anier K., Tamm R., Kallassalu K., and Maeorg U. Determination of thiopurine S-methyltransferase (TPMT) activity by comparing various normalization factors: reference values for Estonian population using HPLC-UV assay. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 834 (2006) 77-83
21. Jacques P.F., Bostom A.G., Wilson P.W., Rich S., Rosenberg I.H., and Selhub J. Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort. Am. J. Clin. Nutr. 73 (2001) 613-621
22. Nygard O., Refsum H., Ueland P.M., and Vollset S.E. Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland Homocysteine Study. Am. J. Clin. Nutr. 67 (1998) 263-270
23. Sadeghian S., Fallahi F., Salarifar M., Davoodi G., Mahmoodian M., Fallah N., et al. Homocysteine, vitamin B12 and folate levels in premature coronary artery disease. BMC Cardiovasc. Disord. 6 (2006) 38
24. Bauer M., Katzenberger J.D., Hamm A.C., Bonaus M., Zinke I., Jaekel J., and Pankratz M.J. Purine and folate metabolism as a potential target of sex-specific nutrient allocation in Drosophila and its implication for lifespan-reproduction tradeoff. Physiol. Genomics 25 (2006) 393-404
25. Park E.I., and Garrow T.A. Interaction between dietary methionine and methyl donor intake on rat liver betaine-homocysteine methyltransferase gene expression and organization of the human gene. J. Biol. Chem. 274 (1999) 7816-7824
26. Schwahn B.C., Chen Z., Laryea M.D., Wendel U., Lussier-Cacan S., Genest Jr. J., et al. Homocysteine-betaine interactions in a murine model of 5,10-methylenetetrahydrofolate reductase deficiency. FASEB J. 17 (2003) 512-514
27. Chadwick L.H., McCandless S.E., Silverman G.L., Schwartz S., Westaway D., and Nadeau J.H. Betaine-homocysteine methyltransferase-2: cDNA cloning, gene sequence, physical mapping, and expression of the human and mouse genes. Genomics 70 (2000) 66-73
28. Karas-Kuzelicki N., and Mlinaric-Rascan I. Individualization of thiopurine therapy: thiopurine S-methyltransferase and beyond. Pharmacogenomics 10 (2009) 1309-1322